# US 2025/0166740 A1 · Multi-instance gpu-based system for discovering drug candidate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0166740 A1
- Document ID: US20250166740A1
- Status: Published application
- Kind: A1
- Application number: 18/878,959
- Filed: 2023-12-21
- Published: 2025-05-22
- Earliest claimed: 2023-07-26
- Assignees: Calici Co., Ltd.
- Applicants: Calici Co., Ltd.
- Inventors: Jae Mun CHOI; Young Bin PARK; Chul SUNG; Van Huong LE; Trong Tue TRAN; Yu Kyung YUN; Jin Hee PARK; Jonathan WILLIANTO; Nuzup SHADIEV
- Web page: https://patentgrep.com/patent/US20250166740A1

## CPC

- G16B 15/30: Drug targeting using structural data; Docking or binding prediction
- G06F 3/0482: Interaction with lists of selectable items, e.g. menus
- G06F 3/0484: for the control of specific functions or operations, e.g. selecting or manipulating an object, an image or a displayed text element, setting a parameter value or selecting a range
- G06F 3/0486: Drag-and-drop
- G06F 9/4881: {Scheduling strategies for dispatcher, e.g. round robin, multi-level priority queues}
- G06F 9/5011: {the resources being hardware resources other than CPUs, Servers and Terminals}
- G06F 9/5027: {the resource being a machine, e.g. CPUs, Servers, Terminals}
- G06N 3/045: Combinations of networks
- G06N 3/0464: Convolutional networks [CNN, ConvNet]
- G06N 3/08: Learning methods
- G06N 20/00: Machine learning
- G06Q 50/10: Services
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 40/20: Supervised data analysis
- G16B 45/00: ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16C 20/20: Identification of molecular entities, parts thereof or of chemical compositions
- G16C 20/40: Searching chemical structures or physicochemical data
- G16C 20/50: Molecular design, e.g. of drugs
- G16C 20/62: Design of libraries
- G16C 20/70: Machine learning, data mining or chemometrics
- G16C 20/80: Data visualisation
- G16C 20/90: Programming languages; Computing architectures; Database systems; Data warehousing
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE

## Abstract

A drug candidate discovery system may include: a project management module configured to create a project for adding a task to perform drug candidate discovery; a simulation management module configured to create a simulation on the created project; a simulation setting module configured to set a simulation workflow for the simulation based on input from a user, using a canvas area and a simulation setting area containing a protein structure data input area and a task module selection area, each containing one or more objects that can be dragged and dropped onto the canvas area and converted into a node; a simulation workflow management module configured to manage information on nodes that can precede or follow in the simulation workflow; and a simulation execution module configured to manage and execute a task for running the simulation workflow by dividing and allocating GPU resource to the respective nodes.

## Claims

### Claim 1

A drug candidate discovery system implemented as a platform that provides functionalities or services required for drug candidate discovery to a user in the form of a web service, comprising:
a project management module configured to create a project for adding a task to perform drug candidate discovery;
a simulation management module configured to create a simulation desired by a user on the created project;
a simulation setting module configured to set a simulation workflow for the simulation based on input from a user, using a canvas area and a simulation setting area comprising a protein structure data input area and a task module selection area, each comprising one or more objects that can be dragged and dropped onto the canvas area and converted into a node;
a simulation workflow management module configured to manage information on nodes that can precede or follow in the simulation workflow;
a simulation execution module configured to manage and execute a task for running the simulation workflow by dividing and allocating GPU resource to the respective nodes; and
a task provisioning module configured to provide a plurality of tasks for performing drug candidate discovery, corresponding to elements of the simulation workflow set by dragging and dropping onto the canvas area by a user,
wherein:
the GPU resource comprises a virtual GPU,
the virtual GPU is assigned a first capacity representing the capacity supported by the virtual GPU,
for each of the plurality of tasks, a second capacity representing the capacity required during task execution is assigned,
for each of the plurality of tasks, the first capacity is compared with the second capacity to determine executability, and
the second capacity is modified to a different value by the user.

### Claim 2 (depends on 1)

The drug candidate discovery system of claim 1, wherein the simulation execution module comprises:
a task management module configured to schedule an execution of the task using a task queue; and
a GPU management module configured to manage GPU based on a multi-instance GPU using a Docker container and execute the task scheduled by the task management module by utilizing a virtual GPU generated based on the GPU.

### Claim 3 (depends on 2)

The drug candidate discovery system of claim 2, wherein the task provisioning module provides the task stored in the form of the Docker container to the simulation execution module.

### Claim 4 (depends on 3)

The drug candidate discovery system of claim 3, wherein the task provisioning module is configured to allocate to the Docker container and provide to the simulation execution module: a first task for automatically identifying an optimal docking site in a target protein structure, a second task for predicting the tertiary structure of a protein from an amino acid sequence, a third task for analyzing and sorting an actual binding energy (kcal/mol) and providing the analyzed binding energy to a user, a fourth task for converting kcal/mol into Kd/Ki (μM) for selected ligands and performing comparative analysis, and a fifth task for predicting absorption, distribution, metabolism, excretion, and toxicity based on the chemical structure of ligands.

### Claim 5 (depends on 1)

The drug candidate discovery system of claim 1, wherein the system is configured to display on a screen:
a first user interface for receiving, from a user, the number of threads to be used to execute the task on the virtual GPU, and
a second user interface for displaying, on the screen, the number of required tokens that a user must pay to execute the task, wherein the number of tokens increases or decreases based on the number of threads.

### Claim 6 (depends on 1)

The drug candidate discovery system of claim 1, wherein the system is configured to display a screen providing a list of the virtual GPU to the user, and
wherein the list displays: a name identifying the virtual GPU, information on a task module available for the virtual GPU, and a maximum capacity supported by the virtual GPU.

### Claim 7

A drug candidate discovery system implemented as a platform that provides functionalities or services required for drug candidate discovery to a user in the form of a web service, comprising:
a project management module configured to create a project for adding a task to perform drug candidate discovery;
a simulation management module configured to create a simulation desired by a user on the created project;
a simulation setting module configured to set a simulation workflow for the simulation based on input from a user, using a canvas area and a simulation setting area comprising a protein structure data input area and a task module selection area, each comprising one or more objects that can be dragged and dropped onto the canvas area and converted into a node;
a simulation workflow management module configured to manage information on nodes that can precede or follow in the simulation workflow; and
a simulation execution module configured to manage and execute a task for running the simulation workflow by dividing and allocating GPU resource to the respective nodes,
wherein the system is configured to display a first screen providing a list of a server to the user, and
wherein the list displayed on the first screen includes: a name identifying the server, information on a virtual GPU used by the server, port information used to access the server, a total capacity supported by the server, a remaining capacity currently available on the server, and a usability status of the server.

### Claim 8 (depends on 7)

The drug candidate discovery system of claim 7, wherein the system is configured to display a second screen providing a list of a virtual GPU used by the server to a user, and
wherein the list on the second screen includes: a name identifying the server, GPU ID information of the virtual GPU used by the server, type information of the virtual GPU used by the server, a maximum capacity supported by the virtual GPU, a currently available capacity on the virtual GPU, and a usability status of the virtual GPU.

### Claim 9

A drug candidate discovery system implemented as a platform that provides functionalities or services required for drug candidate discovery to a user in the form of a web service, comprising:
a project management module configured to create a project for adding a task to perform drug candidate discovery;
a simulation management module configured to create a simulation desired by a user on the created project;
a simulation setting module configured to set a simulation workflow for the simulation based on input from a user, using a canvas area and a simulation setting area comprising a protein structure data input area and a task module selection area, each comprising one or more objects that can be dragged and dropped onto the canvas area and converted into a node;
a simulation workflow management module configured to manage information on nodes that can precede or follow in the simulation workflow; and
a simulation execution module configured to manage and execute a task for running the simulation workflow by dividing and allocating GPU resource to the respective nodes,
wherein the system is configured to display a first screen providing a list of a task queue to a user, and
wherein the list on the first screen includes: position information of a task inserted into the task queue, URL information associated with the task, information on whether the task inserted into the task queue are released, a name of the task inserted into the task queue, an ID of the task, and the number of threads used to execute the task.

### Claim 10 (depends on 9)

The drug candidate discovery system of claim 9, wherein whether the task inserted into the task queue is executable is determined, and if the task is determined to be executable, the task is executed, and
wherein executability of the task is determined by comparing a capacity required for executing the task with a currently available capacity on the virtual GPU, and the task is determined to be executable if the capacity required for executing the task does not exceed the currently available capacity on the virtual GPU, and not executable if the capacity required for executing the task exceeds the currently available capacity on the virtual GPU.

### Claim 11 (depends on 9)

The drug candidate discovery system of claim 9, wherein the system is configured to display a second screen providing a list to a user, the list including information on a blocked capacity during the execution of the task that was scheduled in the task queue.

### Claim 12 (depends on 1)

The drug candidate discovery system of claim 1, wherein the protein structure data input area comprises one or more objects related to a function of uploading protein structure data, and
wherein the one or more objects can be dragged and dropped onto the canvas area and converted into: a first node configured to receive protein structure data in the form of a PDB (Protein Data Bank) file from a user, a second node configured to receive protein structure data in the form of a PDB code from a user, a third node configured to receive protein structure data in the form of a protein sequence file from a user, or a fourth node configured to receive protein structure data in the form of a protein sequence from a user.

### Claim 13 (depends on 12)

The drug candidate discovery system of claim 12, wherein the task module selection area comprises one or more objects related to functions for performing detailed tasks in drug candidate discovery based on the uploaded protein structure data, and
wherein the one or more objects can be dragged and dropped onto the canvas area and converted into: a fifth node configured to identify an optimal docking site in a target protein structure, a sixth node configured to predict the tertiary structure of a protein from an amino acid sequence, a seventh node configured to analyze and sort actual binding energy (kcal/mol) and provide the analyzed binding energy to a user, or an eighth node configured to convert kcal/mol into Kd/Ki (μM) for selected ligands and perform comparative analysis.

### Claim 14 (depends on 13)

The drug candidate discovery system of claim 13, wherein nodes that can precede the fifth node comprise the first node, the second node, the third node, the fourth node, and the sixth node, and
wherein nodes that can follow the fifth node comprise the seventh node.

### Claim 15 (depends on 13)

The drug candidate discovery system of claim 13, wherein nodes that can precede the sixth node comprise the third node and the fourth node, and
wherein nodes that can follow the sixth node comprise the fifth node.

### Claim 16 (depends on 13)

The drug candidate discovery system of claim 13, wherein nodes that can precede the seventh node comprise the fifth node, and
wherein nodes that can follow the seventh node comprise the eighth node.

### Claim 17 (depends on 1)

The drug candidate discovery system of claim 1, wherein a node connection shape is displayed on the node placed in the canvas area, and
while a user clicks on a node connection shape displayed on the right side of a certain node, the color or shape of a node connection shape displayed on the left side of other connectable node changes.

### Claim 18 (depends on 17)

The drug candidate discovery system of claim 17, wherein the simulation workflow management module manages information for determining whether connections between nodes are possible through metadata.
